Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption

Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption

M. H. Napimoga, E. P. Rocha, C. A. Trindade-da-Silva, A. P. D. Demasi, E. F. Martinez, C. G. Macedo, H. B. Abdalla, A. Bettaieb, F. G. Haj, J. T. Clemente-Napimoga, B. Inceoglu, B. D. Hammock

ARTIGO

Inglês

Agradecimentos: United States Department of Health & Human Services; National Institutes of Health (NIH) - USA;
NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); NIEHS/Superfund Research Program

Soluble epoxide hydrolase (sEH) is an enzyme in the arachidonate cascade which converts epoxy fatty acids (EpFAs), such as epoxyeicosatrienoic acids (EETs) produced by cytochrome P450 enzymes, to dihydroxy-eicosatrienoic acids. In the last 20 years with the development of inhibitors to sEH it has...

CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO - CNPQ

FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULO - FAPESP

Fechado

Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption

M. H. Napimoga, E. P. Rocha, C. A. Trindade-da-Silva, A. P. D. Demasi, E. F. Martinez, C. G. Macedo, H. B. Abdalla, A. Bettaieb, F. G. Haj, J. T. Clemente-Napimoga, B. Inceoglu, B. D. Hammock


										

Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption

M. H. Napimoga, E. P. Rocha, C. A. Trindade-da-Silva, A. P. D. Demasi, E. F. Martinez, C. G. Macedo, H. B. Abdalla, A. Bettaieb, F. G. Haj, J. T. Clemente-Napimoga, B. Inceoglu, B. D. Hammock

    Fontes

    Journal of periodontal research

    Vol. 53, no. 5 (Oct., 2018), p. 743-479